Tags

Type your tag names separated by a space and hit enter

[The influence of chronic pentroxifylline medication on ergometric and hemodynamic parameters in intermittent claudication (author's transl)].
Med Klin. 1979 Jul 13; 74(28-29):1093-6.MK

Abstract

In an open clinical trial 14 patients with intermittent claudication caused by an obliteration of the femoral artery received 400 mg pentoxifylline 3 times daily over a period of 6 months. The walking distance, time to peak flow and calf ergometry showed a significant increase. Minor improvement of working hyperemia and peak flow could be found. The systolic pressure gradient over the obstruction didn't change. No patient complained about side effects.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

556192

Citation

Rudofsky, G, et al. "[The Influence of Chronic Pentroxifylline Medication On Ergometric and Hemodynamic Parameters in Intermittent Claudication (author's Transl)]." Medizinische Klinik, vol. 74, no. 28-29, 1979, pp. 1093-6.
Rudofsky G, Brock FE, Ulrich M, et al. [The influence of chronic pentroxifylline medication on ergometric and hemodynamic parameters in intermittent claudication (author's transl)]. Med Klin. 1979;74(28-29):1093-6.
Rudofsky, G., Brock, F. E., Ulrich, M., & Nobbe, F. (1979). [The influence of chronic pentroxifylline medication on ergometric and hemodynamic parameters in intermittent claudication (author's transl)]. Medizinische Klinik, 74(28-29), 1093-6.
Rudofsky G, et al. [The Influence of Chronic Pentroxifylline Medication On Ergometric and Hemodynamic Parameters in Intermittent Claudication (author's Transl)]. Med Klin. 1979 Jul 13;74(28-29):1093-6. PubMed PMID: 556192.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [The influence of chronic pentroxifylline medication on ergometric and hemodynamic parameters in intermittent claudication (author's transl)]. AU - Rudofsky,G, AU - Brock,F E, AU - Ulrich,M, AU - Nobbe,F, PY - 1979/7/13/pubmed PY - 2000/3/22/medline PY - 1979/7/13/entrez SP - 1093 EP - 6 JF - Medizinische Klinik JO - Med Klin VL - 74 IS - 28-29 N2 - In an open clinical trial 14 patients with intermittent claudication caused by an obliteration of the femoral artery received 400 mg pentoxifylline 3 times daily over a period of 6 months. The walking distance, time to peak flow and calf ergometry showed a significant increase. Minor improvement of working hyperemia and peak flow could be found. The systolic pressure gradient over the obstruction didn't change. No patient complained about side effects. SN - 0025-8458 UR - https://www.unboundmedicine.com/medline/citation/556192/[The_influence_of_chronic_pentroxifylline_medication_on_ergometric_and_hemodynamic_parameters_in_intermittent_claudication__author's_transl_]_ DB - PRIME DP - Unbound Medicine ER -